文献速递胸部肿瘤

肺癌筛查、过度诊断与医疗资源利用:一项全国性人群研究

Screening for Lung Cancer, Overdiagnosis, and Healthcare Utilization: A Nationwide Population-Based Study.
PubMed 文献 · J Thorac Oncol · 2024-12-09

该研究分析韩国国家健康信息数据库及11家学术医院筛查中心1999—2022年数据,评估非报销、自发性低剂量CT筛查的普及情况及其对肺癌流行病学和医疗利用的影响。结果显示,不符合指南的自发筛查在男性从29%升至60%、女性从7%升至46%,女性局部期肺癌发病率近乎翻倍,肺癌手术量在女性中急剧增加。作者结论认为广泛的不符合指南的低剂量CT筛查与肺癌过度诊断和医疗利用增加相关,尤其在女性中。

要点

  • 不符合指南的自发低剂量CT筛查在男性从29%升至60%、女性从7%升至46%。
  • 女性局部期肺癌年龄标化发病率从7.6升至13.7/10万,远处期从16.1降至15.0/10万。
  • 女性肺癌手术(恶性及良性病变)急剧增加,常缺乏非手术活检。

核心结论

  • 广泛的不符合指南的低剂量CT筛查与肺癌过度诊断及医疗利用增加相关,尤其在女性中。
  • 需要随机对照试验评估低风险人群筛查的风险与获益,以确定其有效性和后果。

研究设计与样本

  • 全国性队列研究,分析韩国国家健康信息数据库及11家学术医院筛查中心1999—2022年数据。
  • 采用Joinpoint回归评估趋势变化。

主要发现

  • 健康体检中自发性非报销低剂量CT筛查在男性从29%升至60%、女性从7%升至46%,而仅2.4%男性和0.04%女性符合风险导向筛查条件。
  • 女性局部期肺癌年龄标化发病率从7.6升至13.7/10万,远处期年龄标化发病率从16.1降至15.0/10万。
  • 肺癌年龄标化死亡率从23.3降至19.8/10万,5年生存率大幅改善。
  • 女性肺癌诊断向更早期和更年轻年龄转移。
  • 女性中针对恶性和良性病变的肺部手术急剧增加,且常缺乏非手术活检。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Guideline-discordant low-dose computed tomography (LDCT) screening may cause lung cancer (LC) overdiagnosis, but its extent and consequences are unclear. This study aimed to investigate the prevalence of self-initiated, non-reimbursed LDCT screening in a predominantly non-smoking population and its impact on LC epidemiology and healthcare utilization. METHODS: This nationwide cohort study analyzed data from Korea's National Health Information Database and 11 academic hospital screening centers (1999-2022). The overall analysis encompassed the entire Korean population. For non-reimbursed LDCT screening prevalence, which the National Health Information Database does not capture, a separate analysis was conducted on a cohort of 1.7 million adults to extrapolate nationwide rates. Outcomes included trends in self-initiated, non-reimbursed LDCT screening, LC incidence, mortality, stage and age at diagnosis, 5-year survival, and LC-related healthcare utilization, including surgeries and biopsies. Joinpoint regression assessed trend changes. RESULTS: Self-initiated, non-reimbursed LDCT screening during health check-ups increased from 29% to 60% in men and 7% to 46% in women, despite only 2.4% of men and 0.04% of women qualifying for risk-based screening. In women, localized-stage LC incidence nearly doubled (age-standardized incidence rate: from 7.6 to 13.7 per 100,000), whereas distant-stage incidence decreased (age-standardized incidence rate: from 16.1 to 15.0 per 100,000). LC mortality declined (age-standardized mortality rate: from 23.3 to 19.8 per 100,000), whereas 5-year survival rates improved substantially. LC diagnoses in women shifted towards earlier stages and younger ages. Lung surgeries for both malignant and benign lesions, frequently lacking nonsurgical biopsies, increased sharply in women. CONCLUSIONS: Widespread guideline-discordant LDCT screening correlates with LC overdiagnosis and increased healthcare utilization, particularly in women. Randomized controlled trials are needed to assess the risks and benefits of screening in low-risk populations to determine its efficacy and consequences.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Kim SY, Silvestri GA, Kim YW, et al. Screening for Lung Cancer, Overdiagnosis, and Healthcare Utilization: A Nationwide Population-Based Study. J Thorac Oncol. 2024. PMID: 39662732. doi:10.1016/j.jtho.2024.12.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。